3006

Hainan Poly Pharm. Co., Ltd Stock Price

SZSE:300630 Community·CN¥496.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300630 Share Price Performance

CN¥0.89
-1.38 (-60.79%)
CN¥0.89
-1.38 (-60.79%)
Price CN¥0.89

300630 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low and slightly overvalued.

6 Risks
0 Rewards

Hainan Poly Pharm. Co., Ltd Key Details

CN¥1.3b

Revenue

CN¥365.2m

Cost of Revenue

CN¥941.4m

Gross Profit

CN¥1.0b

Other Expenses

-CN¥106.0m

Earnings

Last Reported Earnings
Sep 30, 2024
Next Reporting Earnings
n/a
-0.19
72.05%
-8.12%
96.7%
View Full Analysis

About 300630

Founded
1992
Employees
1565
CEO
Min Hua Fan
WebsiteView website
www.hnpoly.com

Hainan Poly Pharm. Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China and internationally. The company’s dosage formulations comprise of tablets, capsules, granules, ointments, eye drops, pre-infusion, injection, lyophilization, and oral solutions. It also offers pharmaceutical preparations, active pharmaceutical ingredients, other raw materials, excipients, prescription drugs, and contract manufacturing and contract development and manufacturing services. Hainan Poly Pharm. Co., Ltd. was founded in 1992 and is headquartered in Haikou, China.

Recent 300630 News & Updates

Recent updates

No updates